Amedeo Smart

Free Medical Literature Service



Cytomegalovirus Infection

  Free Subscription

Articles published in
J Infect Dis
    July 2022
  1. SEMMES EC, Permar SR
    Human cytomegalovirus infection primes fetal NK cells for Fc-mediated anti-viral defense.
    J Infect Dis. 2022 Jul 25. pii: 6649429. doi: 10.1093.
    >> Share

  2. VAABEN AV, Levan J, Nguyen CBT, Callaway PC, et al
    In Utero Activation of NK Cells in Congenital CMV Infection.
    J Infect Dis. 2022 Jul 25. pii: 6649436. doi: 10.1093.
    >> Share

    May 2022
  3. KUA KP, Chongmelaxme B, Lee S
    Association between cytomegalovirus infection and tuberculosis disease: A systematic review and meta-analysis of epidemiological studies.
    J Infect Dis. 2022 May 4. pii: 6580085. doi: 10.1093.
    >> Share

    April 2022
  4. PERMAR SR, Kaur A, Fruh K
    De-risking human cytomegalovirus vaccine clinical development in relevant preclinical models.
    J Infect Dis. 2022 Apr 13. pii: 6567687. doi: 10.1093.
    >> Share

  5. LI J, Wellnitz S, Chi XS, Yue Y, et al
    Horizontal transmission of cytomegalovirus in a rhesus model despite high-level, vaccine-elicited neutralizing antibody and T cell responses.
    J Infect Dis. 2022 Apr 12. pii: 6567520. doi: 10.1093.
    >> Share

    February 2022
  6. RAFFERTY H, Murray MJ, Tam JCH, Macfarlane A, et al
    Are the patterns of cytomegalovirus viral load seen after solid organ transplantation affected by circadian rhythm?
    J Infect Dis. 2022 Feb 20. pii: 6532605. doi: 10.1093.
    >> Share

  7. PAVLINAC P, Singa B, Huang ML, Shrestha L, et al
    Cytomegalovirus viremia predicts post-discharge mortality in Kenyan HIV-exposed uninfected children.
    J Infect Dis. 2022 Feb 13. pii: 6527814. doi: 10.1093.
    >> Share

  8. ALANIO C, Verma A, Mathew D, Gouma S, et al
    Cytomegalovirus latent infection is associated with an increased risk of COVID-19-related hospitalization.
    J Infect Dis. 2022 Feb 2. pii: 6520490. doi: 10.1093.
    >> Share

    November 2021
  9. YATES TA, Griffith GJ, Morris TT
    Human Cytomegalovirus and Risk of Incident Cardiovascular Disease in UK Biobank.
    J Infect Dis. 2021 Nov 23. pii: 6433725. doi: 10.1093.
    >> Share

    October 2021
  10. VERBOEKET SO, Wit FW, Verheij E, van Zoest RA, et al
    Human Immunodeficiency Virus (HIV)-Negative Men Who Have Sex With Men Have Higher CD8+ T-Cell Counts and Lower CD4+/CD8+ T-Cell Ratios Compared With HIV-Negative Heterosexual Men.
    J Infect Dis. 2021;224:1187-1197.
    >> Share

  11. LECUYER R, Issa N, Tessoulin B, Lavergne RA, et al
    Epidemiology and clinical impact of respiratory co-infections at diagnosis of Pneumocystis jirovecii Pneumonia.
    J Infect Dis. 2021 Oct 4. pii: 6380657. doi: 10.1093.
    >> Share

    September 2021
  12. SANTOS BRAVO M, Plault N, Sanchez Palomino S, Mosquera Gutierrez MM, et al
    Phenotype and Genotype Study of Novel C480F Maribavir-Ganciclovir Cross-Resistance Mutation Detected in Hematopoietic Stem Cell and Solid Organ Transplant Recipients.
    J Infect Dis. 2021;224:1024-1028.
    >> Share

    July 2021
  13. HAMILTON EM, Allen NE, Mentzer AJ, Littlejohns TJ, et al
    Human cytomegalovirus and risk of incident cardiovascular disease in UK Biobank.
    J Infect Dis. 2021 Jul 19. pii: 6323934. doi: 10.1093.
    >> Share

  14. POLONI C, Szyf M, Cheishvili D, Tsoukas CM, et al
    Are the healthy vulnerable? Cytomegalovirus seropositivity in healthy adults is associated with accelerated epigenetic age and immune-dysregulation.
    J Infect Dis. 2021 Jul 13. pii: 6320592. doi: 10.1093.
    >> Share

    April 2021
  15. STERN A, Su Y, Dumke H, Fang J, et al
    CMV viral load kinetics predict CMV end-organ disease and mortality after hematopoietic cell transplant (HCT).
    J Infect Dis. 2021 Apr 17. pii: 6232014. doi: 10.1093.
    >> Share

    Viral load kinetics: a way to assess cumulative effects of CMV on hematopoietic stem cell transplant recipients.
    J Infect Dis. 2021 Apr 17. pii: 6232022. doi: 10.1093.
    >> Share

    March 2021
  17. SINGH N, Winston DJ, Razonable RR, Lyon GM, et al
    Unexpected CMV replication kinetics in CMV- donor seropositive recipient seronegative liver transplant recipients receiving preemptive antiviral therapy.
    J Infect Dis. 2021 Mar 23. pii: 6182482. doi: 10.1093.
    >> Share

    December 2020
  18. ALTAF M, Lineburg K, Crooks P, Rehan S, et al
    Pre-transplant cytomegalovirus-specific cellular immunity and risk of viral reactivation following lung transplantation: a prospective cohort study.
    J Infect Dis. 2020 Dec 4. pii: 6019998. doi: 10.1093.
    >> Share

    November 2020
  19. DONADEU L, Revilla-Lopez E, Jarque M, Crespo E, et al
    CMV-specific Cell-Mediated Immunity Predicts High level of CMV Replication after Prophylaxis withdrawal in Lung Transplant Recipients.
    J Infect Dis. 2020 Nov 27. pii: 6007492. doi: 10.1093.
    >> Share

  20. IMLAY H, Dasgupta S, Boeckh M, Stapleton RD, et al
    Risk Factors for Cytomegalovirus Reactivation and Association with Outcomes in Critically Ill Adults with Sepsis: A Pooled Analysis of Prospective Studies.
    J Infect Dis. 2020 Nov 7. pii: 5959850. doi: 10.1093.
    >> Share

    October 2020
  21. SLYKER JA, Guthrie B, Pankau M, Tapia K, et al
    Cytomegalovirus and Epstein-Barr virus viremia are associated with HIV DNA levels in the reservoir of Kenyan infants on antiretroviral therapy.
    J Infect Dis. 2020 Oct 16. pii: 5926738. doi: 10.1093.
    >> Share

  22. COX KS, Zhang L, Freed DC, Tang A, et al
    Functional Evaluation and Genetic Evolution of Human T-cell Responses after Vaccination with a Conditionally Replication-Defective Cytomegalovirus Vaccine.
    J Infect Dis. 2020 Oct 8. pii: 5919748. doi: 10.1093.
    >> Share

    September 2020
    Cytomegalovirus and Your Health: Not a Matter of the Heart, Nor of Life and Death.
    J Infect Dis. 2020 Sep 10. pii: 5903620. doi: 10.1093.
    >> Share

  24. CHEN S, Pawelec G, Trompet S, Goldeck D, et al
    Associations of Cytomegalovirus Infection With All-Cause and Cardiovascular Mortality in Multiple Observational Cohort Studies of Older Adults.
    J Infect Dis. 2020 Sep 10. pii: 5903621. doi: 10.1093.
    >> Share

    August 2020
  25. PAEZ-VEGA A, Cantisan S, Aguera ML, Suner M, et al
    Pretransplant CMV-specific T-cell immunity but not dose of antithymocyte globulin is associated with recovery of specific immunity after kidney transplantation.
    J Infect Dis. 2020 Aug 11. pii: 5890921. doi: 10.1093.
    >> Share

    July 2020
  26. SINGH N, Winston DJ, Razonable RR, Lyon GM, et al
    Risk factors for viremia in CMV- recipient seronegative donor seropositive liver transplant recipients who receive preemptive antiviral therapy.
    J Infect Dis. 2020 Jul 29. pii: 5878043. doi: 10.1093.
    >> Share

  27. CHOU S, Song K, Wu J, Bo T, et al
    Drug resistance mutations and associated phenotypes detected in clinical trials of maribavir for treatment of cytomegalovirus infection.
    J Infect Dis. 2020 Jul 29. pii: 5877931. doi: 10.1093.
    >> Share

  28. HASING ME, Pang XL, Mabilangan C, Preiksaitis JK, et al
    Donor cytomegalovirus transmission patterns in solid organ transplant recipients with primary infection.
    J Infect Dis. 2020 Jul 24. pii: 5876001. doi: 10.1093.
    >> Share

  29. VIETZEN H, Gorzer I, Honsig C, Jaksch P, et al
    Human Cytomegalovirus (HCMV)-Specific Antibody Response and Development of Antibody-Dependent Cellular Cytotoxicity Against HCMV After Lung Transplantation.
    J Infect Dis. 2020;222:417-427.
    >> Share

  30. KAMINSKI H, Menard C, El Hayani B, Adjibabi AN, et al
    Characterization of a unique gammadelta T cell subset as a specific marker of CMV infection severity.
    J Infect Dis. 2020 Jul 5. pii: 5867506. doi: 10.1093.
    >> Share

    April 2020
  31. SCHWENDINGER M, Thiry G, De Vos B, Leroux-Roels G, et al
    A Randomized Dose-Escalating Phase I Trial of a Replication-Deficient Lymphocytic Choriomeningitis Virus Vector-Based Vaccine Against Human Cytomegalovirus.
    J Infect Dis. 2020 Apr 21. pii: 5821369. doi: 10.1093.
    >> Share

  32. ALI A, Chiuppesi F, Nguyen M, Hausner MA, et al
    Chimeric Antigen Receptors Targeting Human Cytomegalovirus.
    J Infect Dis. 2020 Apr 13. pii: 5819787. doi: 10.1093.
    >> Share

    March 2020
  33. IMLAY H, Limaye AP
    Current Understanding of Cytomegalovirus Reactivation in Critical Illness.
    J Infect Dis. 2020;221.
    >> Share

  34. LAUGHLIN C, Chakhtoura N, Beisel C, Dempsey W, et al
    Cytomegalovirus Meeting Summary.
    J Infect Dis. 2020;221.
    >> Share

  35. RAZONABLE RR, Inoue N, Pinninti SG, Boppana SB, et al
    Clinical Diagnostic Testing for Human Cytomegalovirus Infections.
    J Infect Dis. 2020;221.
    >> Share

  36. HAIDAR G, Boeckh M, Singh N
    Cytomegalovirus Infection in Solid Organ and Hematopoietic Cell Transplantation: State of the Evidence.
    J Infect Dis. 2020;221.
    >> Share

  37. KRAUSE PR, Roberts J
    Scientific and Regulatory Considerations for Efficacy Studies of Cytomegalovirus Vaccines.
    J Infect Dis. 2020;221.
    >> Share

    Preventing Infection by Human Cytomegalovirus.
    J Infect Dis. 2020;221.
    >> Share

  39. ACOSTA E, Bowlin T, Brooks J, Chiang L, et al
    Advances in the Development of Therapeutics for Cytomegalovirus Infections.
    J Infect Dis. 2020;221.
    >> Share

  40. MUSSI-PINHATA MM, Yamamoto AY
    Natural History of Congenital Cytomegalovirus Infection in Highly Seropositive Populations.
    J Infect Dis. 2020;221.
    >> Share

  41. ROARK HK, Jenks JA, Permar SR, Schleiss MR, et al
    Animal Models of Congenital Cytomegalovirus Transmission: Implications for Vaccine Development.
    J Infect Dis. 2020;221.
    >> Share

  42. KABANI N, Ross SA
    Congenital Cytomegalovirus Infection.
    J Infect Dis. 2020;221.
    >> Share

  43. BRITT WJ
    Human Cytomegalovirus Infection in Women With Preexisting Immunity: Sources of Infection and Mechanisms of Infection in the Presence of Antiviral Immunity.
    J Infect Dis. 2020;221.
    >> Share

  44. PLOTKIN SA, Wang D, Oualim A, Diamond DJ, et al
    The Status of Vaccine Development Against the Human Cytomegalovirus.
    J Infect Dis. 2020;221.
    >> Share

  45. NELSON CS, Baraniak I, Lilleri D, Reeves MB, et al
    Immune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease.
    J Infect Dis. 2020;221.
    >> Share

  46. HODOWANEC AC, Pikis A, Singer ME
    The Development of Therapeutics for the Treatment and Prevention of CMV Disease in the Transplant Population: A Regulatory Perspective.
    J Infect Dis. 2020;221.
    >> Share

  47. LANZIERI TM, Gastanaduy PA, Gambhir M, Plotkin SA, et al
    Review of Mathematical Models of Vaccination for Preventing Congenital Cytomegalovirus Infection.
    J Infect Dis. 2020;221.
    >> Share

  48. GRIFFITHS P, Hughes B
    Choice of Study Populations for Vaccines.
    J Infect Dis. 2020;221.
    >> Share

    February 2020
  49. BEHRENS GA, Brehm M, Gross R, Heider J, et al
    Non-invasive determination of CMV serostatus from dried buccal swab samples: assay development, validation and application to 1.2 million samples.
    J Infect Dis. 2020 Feb 13. pii: 5735315. doi: 10.1093.
    >> Share

    December 2019
  50. JO H, Kwon DE, Han SH, Min SY, et al
    De Novo Genotypic Heterogeneity in the UL56 Region in Cytomegalovirus-infected Tissues: Implications for Primary Letermovir Resistance.
    J Infect Dis. 2019 Dec 5. pii: 5658434. doi: 10.1093.
    >> Share

    November 2019
  51. JAMES SH
    Letermovir Resistance in Hematopoietic Stem Cell Transplant Recipients: The Risks Associated with Cytomegalovirus Prophylaxis.
    J Infect Dis. 2019 Nov 29. pii: 5645460. doi: 10.1093.
    >> Share

  52. DOUGLAS CM, Barnard R, Holder D, Leavitt R, et al
    Letermovir Resistance Analysis in a Clinical Trial of Cytomegalovirus Prophylaxis for Hematopoietic Stem Cell Transplant Recipients.
    J Infect Dis. 2019 Nov 29. pii: 5645458. doi: 10.1093.
    >> Share

  53. ZAMORA D, Krantz EM, Green ML, Joncas-Schronce L, et al
    The Cytomegalovirus Humoral Response Against Epithelial Cell Entry-mediated Infection in the Primary Infection Setting after Hematopoietic Cell Transplantation.
    J Infect Dis. 2019 Nov 18. pii: 5627782. doi: 10.1093.
    >> Share

  54. SMITH C, Moraka NO, Ibrahim M, Moyo S, et al
    HIV Exposure but Not Early CMV Infection is Associated with Increased Hospitalization and Decreased Memory T-cell Responses to Tetanus Vaccine.
    J Infect Dis. 2019 Nov 10. pii: 5618838. doi: 10.1093.
    >> Share

  55. STOCKDALE L, Nash S, Farmer R, Raynes J, et al
    Cytomegalovirus antibody responses associated with increased risk of TB disease in Ugandan adults.
    J Infect Dis. 2019 Nov 5. pii: 5613526. doi: 10.1093.
    >> Share

    October 2019
  56. ROSS S, Pati P, Jensen TL, Goll JB, et al
    Cytomegalovirus genetic diversity following primary infection.
    J Infect Dis. 2019 Oct 8. pii: 5583881. doi: 10.1093.
    >> Share

    April 2019
  57. EL HADDAD L, Ariza-Heredia E, Chemaly RF
    Reply to Gimenez et al.
    J Infect Dis. 2019;219:1512-1513.
    >> Share

    February 2019
  58. BARANIAK I, Kern F, Holenya P, Griffiths P, et al
    Original antigenic sin shapes the immunological repertoire evoked by HCMV gB-MF59 vaccine in seropositive recipients.
    J Infect Dis. 2019 Feb 27. pii: 5366424. doi: 10.1093.
    >> Share

    January 2019
  59. MUENCHHOFF M, Adland E, Roider J, Kloverpris H, et al
    Differential Pathogen-Specific Immune Reconstitution in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Children.
    J Infect Dis. 2019 Jan 8. pii: 5280900. doi: 10.1093.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016